Search
for
Sort by
Research 421–450 of 1000+
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Novel therapies for alopecia areata: The era of rational drug development
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Theoretical investigation on the construction of hair follicle membranes and the transdermal drug delivery mechanisms of JAK inhibitors via distinct pathways
- Alopecia Areata: Current Review
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- Tofacitinib therapy for children with severe alopecia areata
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Hair Follicle Reconstruction and Stem Cells
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Research Progress on the Application of Stem Cells in Hair Regeneration
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- The role of janus kinases in the treatment of autoimmune skin diseases
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Novedades terapéuticas en tricología
- ALOPECIA AREATA: PADRÕES DE QUEDA DE CABELO, MODALIDADES DE TRATAMENTO E IMPACTO PSICOLÓGICO
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study
- Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial